| Literature DB >> 31482137 |
Jonathan R Bull1, Simon P Rowland1, Elina Berglund Scherwitzl1, Raoul Scherwitzl1, Kristina Gemzell Danielsson2, Joyce Harper3.
Abstract
The use of apps that record detailed menstrual cycle data presents a new opportunity to study the menstrual cycle. The aim of this study is to describe menstrual cycle characteristics observed from a large database of cycles collected through an app and investigate associations of menstrual cycle characteristics with cycle length, age and body mass index (BMI). Menstrual cycle parameters, including menstruation, basal body temperature (BBT) and luteinising hormone (LH) tests as well as age and BMI were collected anonymously from real-world users of the Natural Cycles app. We analysed 612,613 ovulatory cycles with a mean length of 29.3 days from 124,648 users. The mean follicular phase length was 16.9 days (95% CI: 10-30) and mean luteal phase length was 12.4 days (95% CI: 7-17). Mean cycle length decreased by 0.18 days (95% CI: 0.17-0.18, R 2 = 0.99) and mean follicular phase length decreased by 0.19 days (95% CI: 0.19-0.20, R 2 = 0.99) per year of age from 25 to 45 years. Mean variation of cycle length per woman was 0.4 days or 14% higher in women with a BMI of over 35 relative to women with a BMI of 18.5-25. This analysis details variations in menstrual cycle characteristics that are not widely known yet have significant implications for health and well-being. Clinically, women who wish to plan a pregnancy need to have intercourse on their fertile days. In order to identify the fertile period it is important to track physiological parameters such as basal body temperature and not just cycle length.Entities:
Keywords: Preclinical research; Reproductive biology
Year: 2019 PMID: 31482137 PMCID: PMC6710244 DOI: 10.1038/s41746-019-0152-7
Source DB: PubMed Journal: NPJ Digit Med ISSN: 2398-6352
Mean cycle lengths, bleed lengths, follicular phase lengths and luteal phase lengths in cohorts by cycle length
| Cycle length range in days | Cycles (% of total) | Mean ± std cycle length in days | Mean ± std bleed length in days | Mean ± std follicular phase length in days | Mean ± std luteal phase length in days |
|---|---|---|---|---|---|
| 15–20 | 3769 (<1%) | 18.4 ± 1.6 | 3.5 ± 1.5 | 10.4 ± 2.4 | 8.0 ± 2.4 |
| 21–24 | 47,449 (8%) | 23.4 ± 0.9 | 3.7 ± 1.4 | 12.4 ± 2.2 | 11.0 ± 2.2 |
| 25–30 | 395,631 (65%) | 27.6 ± 1.6 | 3.9 ± 1.4 | 15.2 ± 2.5 | 12.4 ± 2.2 |
| 31–35 | 116,998 (19%) | 32.4 ± 1.3 | 4.1 ± 1.5 | 19.5 ± 2.7 | 12.9 ± 2.3 |
| 36–50 | 43,240 (7%) | 39.8 ± 3.7 | 4.2 ± 1.7 | 26.8 ± 4.5 | 12.9 ± 2.8 |
| All cycles (10–90) | 612,613 | 29.3 ± 5.2 | 4.0 ± 1.5 | 16.9 ± 5.3 | 12.4 ± 2.4 |
Mean cycle lengths, bleed lengths, per-user cycle length variations, follicular phase lengths and luteal phase lengths in cohorts of cycles by user age
| Age range in years | Users (% of total) | Cycles (% of total) | Mean ± std cycle length in days | Mean ± std bleed length in days | Mean ± std per-user cycle length variation in days | Mean ± std follicular phase length in days | Mean ± std luteal phase length in days |
|---|---|---|---|---|---|---|---|
| 18–24 | 13,391 (11%) | 50,789 (8%) | 30.3 ± 5.7 | 4.2 ± 1.4 | 2.9 ± 2.7 | 18.0 ± 5.7 | 12.2 ± 2.5 |
| 25–29 | 43,297 (35%) | 209,968 (34%) | 29.9 ± 5.5 | 4.0 ± 1.4 | 2.8 ± 2.7 | 17.6 ± 5.6 | 12.3 ± 2.4 |
| 30–34 | 41,571 (33%) | 207,156 (34%) | 29.2 ± 5.1 | 3.9 ± 1.5 | 2.6 ± 2.4 | 16.8 ± 5.2 | 12.4 ± 2.3 |
| 35–39 | 19,410 (16%) | 102,553 (17%) | 28.2 ± 4.4 | 3.8 ± 1.5 | 2.3 ± 2.1 | 15.7 ± 4.5 | 12.5 ± 2.4 |
| 40–45 | 6,948 (6%) | 42,044 (7%) | 27.4 ± 4.3 | 3.7 ± 1.5 | 2.4 ± 2.4 | 14.8 ± 4.3 | 12.5 ± 2.4 |
| All cycles | 124,646 | 612,613 | 29.3 ± 5.2 | 4.0 ± 1.5 | 2.6 ± 2.5 | 16.9 ± 5.3 | 12.4 ± 2.4 |
Fig. 1Age versus mean cycle length ±2 standard errors of the mean (blue). Linear regression (black) fitted in the range 25–45 with 95% CI (pink). Points are labelled with the number of users followed by the number of cycles
Fig. 4Age versus mean per-user cycle length variation ±2 standard errors of the mean (blue). Linear regression (black) fitted in the range 25–40 with 95% CI (pink). Points are labelled with the number of users followed by the number of cycles
Fig. 2Age versus mean follicular phase length ±2 standard errors of the mean (blue). Linear regression (black) fitted in the range 25–45 with 95% CI (pink). Points are labelled with the number of users followed by the number of cycles
Fig. 3Age versus mean luteal phase length ±2 standard errors of the mean. Points are labelled with the number of users followed by the number of cycles
Mean cycle lengths, bleed lengths, per-user cycle length variations, follicular phase lengths and luteal phase lengths in cohorts of cycles by user BMI
| BMI range in kg m−2 | Users (% of total) | Cycles (% of total) | Mean ± std cycle length in days | Mean ± std bleed length in days | Mean ± std per-user cycle length variation in days | Mean ± std follicular phase length in days | Mean ± std luteal phase length in days |
|---|---|---|---|---|---|---|---|
| 15–18.5 | 5040 (4%) | 25,735 (4%) | 29.6 ± 5.2 | 4.2 ± 1.5 | 2.7 ± 2.5 | 16.4 ± 5.4 | 13.1 ± 2.1 |
| 18.5–25 | 83,791 (70%) | 431,667 (72%) | 29.3 ± 5.2 | 4.0 ± 1.5 | 2.7 ± 2.5 | 16.3 ± 5.3 | 12.8 ± 2.1 |
| 25–30 | 20,912 (18%) | 100,228 (17%) | 29.1 ± 5.2 | 3.9 ± 1.4 | 2.6 ± 2.6 | 16.3 ± 5.3 | 12.7 ± 2.2 |
| 30–35 | 6153 (5%) | 26,483 (4%) | 29.3 ± 5.6 | 3.9 ± 1.4 | 2.7 ± 2.7 | 16.6 ± 5.6 | 12.6 ± 2.1 |
| 35–50 | 3145 (3%) | 12,011 (2%) | 29.8 ± 6.0 | 4.0 ± 1.5 | 3.0 ± 3.1 | 17.2 ± 6.0 | 12.4 ± 2.1 |
| All cycles | 124,646 | 612,613 | 29.3 ± 5.2 | 4.0 ± 1.5 | 2.6 ± 2.5 | 16.9 ± 5.3 | 12.4 ± 2.4 |
Fig. 5BMI versus mean per-user cycle length variation ±2 standard errors of the mean. Points are labelled with the number of users followed by the number of cycles
Fig. 6Typical temperature chart in a biphasic menstrual cycle as seen in the app. Shown here are the fertile/nonfertile days (red/green) returned by the algorithm. The fertile window days are darker red. Days with measurements are shown as filled circles. The cycle average temperature (cover line) is the grey horizontal line at 36.37 °C
Fig. 7Flow diagram of user and cycle selection for study. *Eligible users met requirements on registration date, hormone use and medical conditions at the time of registration